Infect Chemother.  2013 Mar;45(1):105-107.

Serratia marcescens Peritonitis in a Diabetic Patient Receiving Continuous Ambulatory Peritoneal Dialysis

Affiliations
  • 1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea. skimw@chonnam.ac.kr

Abstract

We report a case of Serratia marcescens peritonitis in a 45-year-old man with insulin-dependent diabetes mellitus undergoing continuous ambulatory peritoneal dialysis (CAPD). The patient presented with abdominal pain and cloudy dialysate. Empiric antibiotic therapy was initiated intraperitoneally with cefazolin and ceftazidime for 5 days. Cultures of the dialysate revealed S. marcescens, and the treatment was subsequently changed to gentamicin and ceftazidime. Oral ciprofloxacin was also added. The patient's abdominal pain and the dialysate white blood cell (WBC) count, however, did not improve. The indwelling CAPD catheter was therefore removed. This is an unusual case report in the Korean literature of S. marcescens peritonitis in a patient receiving CAPD.

Keyword

Serratia marcescens; Continuous ambulatory peritoneal dialysis; Peritonitis

MeSH Terms

Abdominal Pain
Catheters
Cefazolin
Ceftazidime
Ciprofloxacin
Diabetes Mellitus, Type 1
Gentamicins
Humans
Leukocytes
Peritoneal Dialysis, Continuous Ambulatory
Peritonitis
Serratia
Serratia marcescens
Cefazolin
Ceftazidime
Ciprofloxacin
Gentamicins
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr